SEC
SlamSEC
SearchBrowseEarnings

Allogene Therapeutics, Inc.

Nasdaq:ALLO
Biological Products, (No Diagnostic Substances)·SOUTH SAN FRANCISCO, CA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Credit & Agreementsmaterial agreements · debt obligations

Credit & Agreements (8-K)

9 shown
FiledDescription
2/25/25
1.01
Material Agreement
→
5/31/24
1.01
Material Agreement
→
1/31/24
1.01
Material Agreement
→
1/5/24
1.01
Material Agreement
→
12/15/21
1.01
Material Agreement
→
12/15/20
1.01
Material Agreement
→
↓ 3 more
CEO
Chang David D
CFO
Parker Geoffrey M.